Sam Walton-Troy

Rosotics builds the worlds largest metal 3D printers, for air, sea + defense.

At Chef we believe that AI’s biggest impact will be on the physical world, representing 90% of Global GDP. In the food industry, for example, in 2023 there were 1,137,000 jobs unfilled in food preparation and service (Bureau for Labor Statistics). These growing labor shortages are forcing food companies to leave millions of dollars on the table every year in unmet demand. As this pain becomes more acute, food companies are more aggressively seeking out alternatives, including off-shoring more and more parts of the food supply chain to other countries where there is more labor available; this of course comes with its own significant risks for the US. Chef Robotics offers a new way for food companies to overcome their labor shortage and increase production volume using AI-enabled robots that mimic the flexibility of humans. Chef allows companies to maximize revenue by meeting demand, while keeping the American food supply chain onshore. Chefs mission is to accelerate the advent of intelligent machines in the world to empower humans to do what humans do best.

Menten AI is a drug discovery company focused on designing peptides for conditions with high unmet medical need. We are developing the worlds most advanced generative AI platform for peptide therapeutics.

𝗛𝘂𝗺𝗮𝗻𝗼𝗱𝗲 is the first crypto-biometric network where One human = One node that brings sybil resistance and innovative governance models to the crypto industry using private biometric technology.

Fast-tracking the electric future! EARTH AI is a predictive explorer and driller for critical metals

Orbit Fab envisions a thriving in-space market for products and services that support both existing space businesses (communications and Earth observation) and new industries like space tourism, manufacturing, and mining. The first step is achieving ubiquitous availability of satellite propellant in Earth orbit, expanding the operational potential of new and existing space assets and providing unprecedented business model flexibility for satellite owners. The future for satellites is no longer restricted to the fuel they are launched with. It is about getting the fuel and other materials they need, where and when they need it, to accomplish things never before thought possible.

Ligandal is a genetic medicine company that uses nanotechnology to develop targeted and personalised therapies. As a regenerative medicine biotechnology company, Ligandal develops ultra-rapid therapeutics and vaccines for outbreaks and pandemics, in addition to its work in immuno-oncology and rare genetic diseases. Our current focus is on delivering a peptide-based cure to the COVID-19 pandemic (SARS-CoV-2 coronavirus), as part of a broader mission of enabling personalized medicine on a global scale through the power of nanomedicine and gene therapies. Given that increasingly complex disease states require precise and custom-tailored medicine, much of our technology development has focused on combining gene therapy with targeting peptides to enable completely new paradigms in evolutionary medicine. Currently, we are utilizing a peptide nanoscaffold based approach for treating COVID-19 without a gene therapy component, with the goal of creating a combined antidote-vaccine. My expertise lies in targeted gene delivery, nano- and biomaterials, computational modeling of peptides, binding simulations, immunoengineering, as well as CRISPR and TALEN based gene editing. At Ligandal, we have demonstrated peptide-based delivery of CRISPR, RNA, DNA, siRNA, and a range of genes or proteins to virtually any cell type.

We are building a better way to build, deploy, and scale event-driven AI applications.

Clinical teams trust Brellium to reduce compliance risks, improve quality, and save time. By automatically auditing every patient visit against clinical and payer requirements, Brellium helps you proactively identify and fix documentation errors. With Brellium, you can rest easy knowing your clinic is compliant and nothing slips through the cracks.

For years, security leaders have been told that preparing for post-quantum cryptography (PQC) would take years, cost millions and require deep in-house expertise. QuSecure Inc., the market leader in quantum-safe security, is proving otherwise with its new QuProtect R3, the industry’s first and only fully integrated, production-ready PQC platform designed to make encryption modernization simple for everyone. With the platform’s Reconnaissance innovation, a complimentary module for qualified companies, QuProtect R3 delivers instant visibility into vulnerable encryption across modern, legacy and cloud systems — a capability competitors cannot match. Security teams that once spent months and millions compiling a cryptographic bill of materials (CBOM) can now discover their encryption landscape in days, prioritize the highest-risk systems and act without disrupting operations. Visit us: https://qusecure.com

Inhalon Biopharma is developing an inhaled immunotherapy platform for treating acute respiratory infections (ARI), such as syncytial virus (RSV), influenza, metapneumovirus (MPV), parainfluenza virus (PIV), adenovirus, severe acute respiratory syndrome (SARS) and middle east respiratory syndrome (MERS). Today there are no approved treatments for a wide range of ARIs that can lead to hospitalization, long-term health complications and sometimes death. Our breakthrough discovery enables inhaled antibodies to trap pathogens (i.e. viruses, bacteria, fungi) in the lung mucus, which in turn block the infections from further spreading locally and facilitate the rapid elimination of the pathogens from the lung through normal mucus clearance. Although mucus in the lung airways is designed to protect the body from infections, pathogens have evolved to move easily through mucus to infect cells in the airways. Inhalon was launched based on the discovery of a new immune function – antibodies trapping pathogens in mucus – and molecular and biophysical insights into how to tune the antibody-mucin affinity. These “muco-trapping” antibodies bind to pathogens and crosslink them to mucins. Trapped pathogens are unable to infect cells and are rapidly eliminated by normal mucus clearance every 30 to 60 minutes – swept into the digestive tract and become sterilized by gastric acid. This muco-trapping function is mediated by glycans in the antibody’s Fc region and enhanced through the normal glycosylation process using Inhalon engineered production cell lines. This muco-trapping phenomenon has been confirmed with over a half dozen pathogens to date.

Neural combines the power of proprietary space technology, AI and cloud computing to deploy solutions that turn isolated data into powerful insights and applications for industry leaders. From uncovering market trends to fine-tuning operations and understanding market shifts before they happen, were not just predicting the future — were building it.

Supersourcing is an AI recruitment platform that helps you skip CV screening and tedious interview rounds, and save up to 90% time by either hiring a software engineer or your entire engineering team with us. AI-Powered Recruitment: We solve the challenge of slow tech hiring with AI-driven solutions, delivering vetted developers 10x faster. No more endless screenings—just top-tier talent, ready to go. Quality & Speed: Our smart vetting process ensures you get top developers profiles within 24-48 hours Flexible Engagement Models: Whether you need full-time, contract, or project-based hires, we offer flexible solutions to meet your scaling needs. Comprehensive Support: From onboarding to post-hire, we provide end-to-end support with real-time updates and dedicated account managers to ensure smooth hiring. Trusted by Top Brands: Leading global companies rely on us for their critical tech hiring needs, from startups to enterprises. FAQs: 1. What is the average time to fill a role? - We typically match roles within 24-48 hours. 2. Can I hire globally? - Yes, we provide access to developers worldwide. 3. Do you offer post-hire support? - Yes, our team provides ongoing support to ensure success after hiring. Focus on what you do best – growing your business. Let Supersourcing take care of your talent hiring needs with the precision and efficiency that only AI can provide.

uSTADIUM is a startup and platform where sports fans are rewarded for their predictions.

Rosotics builds the worlds largest metal 3D printers, for air, sea + defense.

At Chef we believe that AI’s biggest impact will be on the physical world, representing 90% of Global GDP. In the food industry, for example, in 2023 there were 1,137,000 jobs unfilled in food preparation and service (Bureau for Labor Statistics). These growing labor shortages are forcing food companies to leave millions of dollars on the table every year in unmet demand. As this pain becomes more acute, food companies are more aggressively seeking out alternatives, including off-shoring more and more parts of the food supply chain to other countries where there is more labor available; this of course comes with its own significant risks for the US. Chef Robotics offers a new way for food companies to overcome their labor shortage and increase production volume using AI-enabled robots that mimic the flexibility of humans. Chef allows companies to maximize revenue by meeting demand, while keeping the American food supply chain onshore. Chefs mission is to accelerate the advent of intelligent machines in the world to empower humans to do what humans do best.

Menten AI is a drug discovery company focused on designing peptides for conditions with high unmet medical need. We are developing the worlds most advanced generative AI platform for peptide therapeutics.

𝗛𝘂𝗺𝗮𝗻𝗼𝗱𝗲 is the first crypto-biometric network where One human = One node that brings sybil resistance and innovative governance models to the crypto industry using private biometric technology.

Fast-tracking the electric future! EARTH AI is a predictive explorer and driller for critical metals